Comparative Efficacy of Tocilizumab and Baricitinib Administration in COVID-19 Treatment: A Retrospective Cohort Study

Background and Objectives: Tocilizumab and baricitinib have been observed to improve the outcomes of patients with coronavirus disease 2019 (COVID-19). However, a comparative evaluation of these drugs has not been performed. Materials and Methods: A retrospective, single-center study was conducted u...

Descripción completa

Detalles Bibliográficos
Autores principales: Kojima, Yuichi, Nakakubo, Sho, Takei, Nozomu, Kamada, Keisuke, Yamashita, Yu, Nakamura, Junichi, Matsumoto, Munehiro, Horii, Hiroshi, Sato, Kazuki, Shima, Hideki, Suzuki, Masaru, Konno, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030469/
https://www.ncbi.nlm.nih.gov/pubmed/35454352
http://dx.doi.org/10.3390/medicina58040513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030469/
https://www.ncbi.nlm.nih.gov/pubmed/35454352
http://dx.doi.org/10.3390/medicina58040513

Ejemplares similares